DANIEL LEUNG to Aspartate Aminotransferases
This is a "connection" page, showing publications DANIEL LEUNG has written about Aspartate Aminotransferases.
Connection Strength
1.087
-
Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015 Nov; 62(5):1576-83.
Score: 0.503
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver Int. 2023 06; 43(6):1277-1286.
Score: 0.212
-
Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis. Clin Gastroenterol Hepatol. 2019 11; 17(12):2561-2569.e5.
Score: 0.160
-
MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis. Hepatology. 2018 12; 68(6):2301-2316.
Score: 0.156
-
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Jan 01; 81(1):358-379.
Score: 0.056